Indeed, most of the subjects bearing either heterozygous or homozygous GBA1 mutations do not develop PD or aSyn aggregate deposition, supporting that other factors participate in linking reduced GCase activity to aSyn pathology [155,156]. The gene discussed is GBA1; the disease is Parkinson disease.